Clinical trials

Next steps for the EU Clinical Trials Directive

Interviewee/Contributer: Kate Law

Organisation: Cancer Research UK

Full text available to subscribers only. Click here for information on subscribing to MedNous.

An analysis of accelerated approval for cancer drugs

Interviewee/Contributer: Bruno Pagliara

Organisation: On-Kos Pharma Consulting

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Vaccine for Parkinson's disease enters the clinic for the first time

Interviewee/Contributer: Walter Schmidt

Organisation: Affiris AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Reforming the EU Clinical Trials Directive

Interviewee/Contributer: Kate Law

Organisation: Cancer Research UK

Full text available to subscribers only. Click here for information on subscribing to MedNous.

The outlook for new clinical trials legislation in Europe

Interviewee/Contributer: Karen Finn

Organisation: MedNous

Full text available to subscribers only. Click here for information on subscribing to MedNous.

How cannabis medicines gained legitimacy

Interviewee/Contributer: Roger Pertwee

Organisation: University of Aberdeen

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Denmark has introduced new procedures for ADRs

Interviewee/Contributer: Henrik Jensen

Organisation: Danish Medicines Agency

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Finding solutions to drug resistance

Interviewee/Contributer: Laura Smart

Organisation: Tiber Creek Partners LLC

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Analysis of Special Protocol Assessments for oncology

Interviewee/Contributer: Bruno Pagliara

Organisation: On-Kòs Pharma Consulting

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Drug development – travelling together?

Interviewee/Contributer: Jytte Lyngvig

Organisation: Danish Medicines Agency

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content